Biosig ceo kenneth l. londoner to present at the oppenheimer 31st annual healthcare conference

Westport, ct, march 10, 2021 (globe newswire) -- biosig technologies, inc. (nasdaq: bsgm) ("biosig" or the "company"), a medical technology company commercializing an innovative signal processing platform designed to improve signal fidelity and uncover the full range of ecg and intra-cardiac signals, today announced that the company has been invited to attend the oppenheimer 31st annual healthcare conference on thursday, march 18, 2021. kenneth l. londoner, chairman and ceo of biosig technologies, will be participating in a virtual fireside chat at 8:00 am et. mr. londoner will also be available for investor meetings.
BSGM Ratings Summary
BSGM Quant Ranking